Cargando…
Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism
BACKGROUND: Patients with salt-sensitive hypertension are often accompanied with severe renal damage and accelerate to end-stage renal disease, which currently lacks effective treatment. Fibroblast growth factor 21 (FGF21) has been shown to suppress nephropathy in both type 1 and type 2 diabetes mic...
Autores principales: | Weng, Hua-Chun, Lu, Xin-Yu, Xu, Yu-Peng, Wang, Yi-Hong, Wang, Dan, Feng, Yi-Ling, Chi, Zhang, Yan, Xiao-Qing, Lu, Chao-Sheng, Wang, Hong-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590333/ https://www.ncbi.nlm.nih.gov/pubmed/34773993 http://dx.doi.org/10.1186/s10020-021-00408-x |
Ejemplares similares
-
Therapeutic Effects of Fibroblast Growth Factor-21 on Diabetic Nephropathy and the Possible Mechanism in Type 1 Diabetes Mellitus Mice
por: Weng, Wenya, et al.
Publicado: (2020) -
A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (rhFGF21) Modified with Polyethylene Glycol
por: Huang, Zhifeng, et al.
Publicado: (2011) -
Attenuation of Hyperlipidemia- and Diabetes-Induced Early-Stage Apoptosis and Late-Stage Renal Dysfunction via Administration of Fibroblast Growth Factor-21 Is Associated with Suppression of Renal Inflammation
por: Zhang, Chi, et al.
Publicado: (2013) -
Intravitreal Injection of PACAP Attenuates Acute Ocular Hypertension–Induced Retinal Injury Via Anti-Apoptosis and Anti-Inflammation in Mice
por: Lu, Peng, et al.
Publicado: (2022) -
The Gut Microbiome, Inflammation, and Salt-Sensitive Hypertension
por: Elijovich, Fernando, et al.
Publicado: (2020)